semaglutide ckd trial Kidney and Survival Outcomes with by... : Clinical Journal of the American Society of Nephrology Effects of semaglutide with and

Published on July 13th, 2025

The pill is available to people with a BMI of 30 and above (generally considered obese) or a BMI of 27-30 (overweight) if they also have certain weight-related health conditions, such as type 2 diabetes or high blood pressure

31, 2024 (stating FDA regulations relating to the advertising and promotion of prescription drugs, including prescription compounded drugs, also require that promotional materials for prescription drugs not be false or misleading

Scientists are examining how it could reduce the risk of liver disease and heart complications associated with obesity

This study examines the efficacy and safety of semaglutide for weight management, including any adverse events that could relate to allergic responses